Jong Keun Song
Research Subjects
Jong Keun Song has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Kyu-Ho Yi
Division in Anatomy and Developmental Biology, Department of Oral Biology, Human Identification Research Institute, BK21 FOUR Project, Yonsei University College of Dentistry, Seoul 03722, Republic of Korea
15 shared publications - Han Earl Lee
Opening Plastic Surgery Clinic, Seoul 06038, Republic of Korea
6 shared publications - Isabella Rosellini
Avery Clinic, Malang, Indonesia
6 shared publications - Jin-Hyun Kim
You and I Clinic, Seoul 06123, Republic of Korea
5 shared publications - Olena Sydorchuk
Medical Research Inc., Wonju, Korea
4 shared publications - Jin-Hyun Kim
You and I Clinic, Seoul, Korea
3 shared publications
Latest Publications
- 2 October 2026
- Published by Wolters Kluwer Health in Journal of Craniofacial Surgery
Hypertonic Dextrose in Aesthetic Dermatology: Route-Dependent Evidence, Biological Rationale, and Research Priorities
Objective: To critically evaluate whether local hypertonic dextrose has sufficient biological and clinical support to be considered an independent dermal biostimulant in aesthetic dermatology. Methods: PubMed/MEDLINE was searched from inception through June, 2026, with backward and forward citation tracking. Direct evidence included human aesthetic or dermatologic studies using local dextrose and translational studies examining dermal delivery or tissue response. Evidence was appraised by design, comparator, blinding, cointerventions, outcome validity, follow-up, and directness to a dextrose-specific effect. Results: Six human reports enrolled 125 participants in aggregate, and 2 translational studies examined pneumatic delivery. Favorable signals were reported for facial laxity, atrophic lesions, pores, fine wrinkles, and acne-scar volume. However, every human protocol included pneumatic pressure, microneedling, focused ultrasound, hyaluronic acid, or another active cointervention. A 5% versus 20% split-face study supports a concentration-dependent or osmolarity-dependent signal within pneumatic delivery, not glucose-specific neocollagenesis. Translational studies demonstrate device-induced tissue injury and penetration into fat and fascia. Reported adverse events were mainly transient; 2 cases of postinflammatory hyperpigmentation occurred in one 30-patient series. Conclusion: Hypertonic dextrose should be regarded as an investigational, route-dependent adjunct rather than an established stand-alone biostimulant. Controlled trials should isolate device, vehicle, osmolarity, and glucose-specific effects and include objective structural endpoints and long-term safety follow-up.
- 2 October 2026
- Published by Wolters Kluwer Health in Journal of Craniofacial Surgery
Hypertonic Dextrose in Aesthetic Dermatology: Route-Dependent Evidence, Biological Rationale, and Research Priorities
Objective: To critically evaluate whether local hypertonic dextrose has sufficient biological and clinical support to be considered an independent dermal biostimulant in aesthetic dermatology. Methods: PubMed/MEDLINE was searched from inception through June, 2026, with backward and forward citation tracking. Direct evidence included human aesthetic or dermatologic studies using local dextrose and translational studies examining dermal delivery or tissue response. Evidence was appraised by design, comparator, blinding, cointerventions, outcome validity, follow-up, and directness to a dextrose-specific effect. Results: Six human reports enrolled 125 participants in aggregate, and 2 translational studies examined pneumatic delivery. Favorable signals were reported for facial laxity, atrophic lesions, pores, fine wrinkles, and acne-scar volume. However, every human protocol included pneumatic pressure, microneedling, focused ultrasound, hyaluronic acid, or another active cointervention. A 5% versus 20% split-face study supports a concentration-dependent or osmolarity-dependent signal within pneumatic delivery, not glucose-specific neocollagenesis. Translational studies demonstrate device-induced tissue injury and penetration into fat and fascia. Reported adverse events were mainly transient; 2 cases of postinflammatory hyperpigmentation occurred in one 30-patient series. Conclusion: Hypertonic dextrose should be regarded as an investigational, route-dependent adjunct rather than an established stand-alone biostimulant. Controlled trials should isolate device, vehicle, osmolarity, and glucose-specific effects and include objective structural endpoints and long-term safety follow-up.
- Open Access
- 1 May 2026
- Published by Elsevier in JPRAS Open
- Vol. 50, 208-215
An anatomy-guided multi-vector thread lifting strategy for nasolabial fold correction: Technique refinement and clinical outcomes in a 22-patient case series
- 1 May 2026
- Published by Elsevier in JPRAS Open
- Vol. 50, 208-215
Open AccessAn anatomy-guided multi-vector thread lifting strategy for nasolabial fold correction: Technique refinement and clinical outcomes in a 22-patient case series
- Open Access
- 19 February 2026
- Published by Elsevier in JPRAS Open
- Vol. 49, 267-271
Ideal Sized Chitosan (Arche) as a multifunctional biomaterial in aesthetic treatment
- 19 February 2026
- Published by Elsevier in JPRAS Open
- Vol. 49, 267-271
Open AccessIdeal Sized Chitosan (Arche) as a multifunctional biomaterial in aesthetic treatment
- 26 January 2026
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 50 (5) , 1944-1952
Hybrid Poly-D,L-Lactic Acid and Autologous Fat Transfer for Forehead Augmentation
Background Forehead augmentation is a foundational procedure for facial harmonisation, particularly in Asian populations where a smooth, convex forehead is aesthetically desirable. Existing modalities such as implants, hyaluronic acid fillers, and fat grafting alone have limitations including irregular contours, surgical risks, or inconsistent long-term retention. Objective To evaluate the 12-month safety, efficacy, and volume stability of sequential poly-D,L-lactic acid (PDLLA) and autologous fat transfer for forehead augmentation. Methods A retrospective case series of 44 Korean patients (32 females, 12 males; mean age 42.3 years) treated between January–December 2024. All patients received 1 vial of Juvelook GLAM (reconstituted in 15 ml) followed by 20–25 ml of purified autologous fat injected using a multi-directional cannula fanning technique. Outcomes were assessed using the Global Aesthetic Improvement Scale (GAIS), modified Carruthers Forehead Contour Scale, standardised photography, and patient-reported satisfaction at 6 and 12 months. Results At 12 months, 39 patients (88.6%) maintained moderate-to-marked improvement on the GAIS, compared with 40 patients (90.9%) at 6 months. Mean satisfaction at 12 months was 8.1/10 (compared with 8.3/10 at 6 months). Clinical assessment confirmed sustained convexity and contour retention, with an estimated 72–78% mean fat graft retention. Complications remained minor and transient: swelling (29.5%), bruising (11.3%), and mild erythema (15.9%). No granulomas, vascular events, infections, or long-term adverse events occurred. Conclusions The combined PDLLA–fat technique provided stable 12-month outcomes, with minimal decline from 6-month results. PDLLA appears to support adipocyte viability and scaffold integration, contributing to improved retention beyond traditional fat grafting. Longer prospective comparative studies are needed to confirm additive effects and 24-month durability. Level of Evidence V This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
- 26 January 2026
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 50 (5) , 1944-1952
Hybrid Poly-D,L-Lactic Acid and Autologous Fat Transfer for Forehead Augmentation
Background Forehead augmentation is a foundational procedure for facial harmonisation, particularly in Asian populations where a smooth, convex forehead is aesthetically desirable. Existing modalities such as implants, hyaluronic acid fillers, and fat grafting alone have limitations including irregular contours, surgical risks, or inconsistent long-term retention. Objective To evaluate the 12-month safety, efficacy, and volume stability of sequential poly-D,L-lactic acid (PDLLA) and autologous fat transfer for forehead augmentation. Methods A retrospective case series of 44 Korean patients (32 females, 12 males; mean age 42.3 years) treated between January–December 2024. All patients received 1 vial of Juvelook GLAM (reconstituted in 15 ml) followed by 20–25 ml of purified autologous fat injected using a multi-directional cannula fanning technique. Outcomes were assessed using the Global Aesthetic Improvement Scale (GAIS), modified Carruthers Forehead Contour Scale, standardised photography, and patient-reported satisfaction at 6 and 12 months. Results At 12 months, 39 patients (88.6%) maintained moderate-to-marked improvement on the GAIS, compared with 40 patients (90.9%) at 6 months. Mean satisfaction at 12 months was 8.1/10 (compared with 8.3/10 at 6 months). Clinical assessment confirmed sustained convexity and contour retention, with an estimated 72–78% mean fat graft retention. Complications remained minor and transient: swelling (29.5%), bruising (11.3%), and mild erythema (15.9%). No granulomas, vascular events, infections, or long-term adverse events occurred. Conclusions The combined PDLLA–fat technique provided stable 12-month outcomes, with minimal decline from 6-month results. PDLLA appears to support adipocyte viability and scaffold integration, contributing to improved retention beyond traditional fat grafting. Longer prospective comparative studies are needed to confirm additive effects and 24-month durability. Level of Evidence V This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
- Top Cited PapersOpen Access
- 15 January 2026
- Published by Elsevier in JPRAS Open
- Vol. 48, 828-845
Facial bone aging: An update and literature review
- 15 January 2026
- Published by Elsevier in JPRAS Open
- Vol. 48, 828-845
Top Cited PapersOpen AccessFacial bone aging: An update and literature review
- 7 January 2026
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 50 (11) , 4212-4217
Comparative Pain Assessment of Intradermal Versus Subdermal Skin Booster Injections Using PDLLA: A Randomized, Double-Blinded Split-Injection Study
Background Poly-D,L-lactic acid (PDLLA) skin boosters are widely used for biostimulatory skin rejuvenation, but comparative data on pain perception between injection techniques remain limited. Objective To compare patient-reported pain between intradermal and subdermal PDLLA injections using a randomized, double-blinded, split-injection design. Methods Twenty-one healthy participants (aged 27–64) each received ten facial injections: five intradermal and five subdermal, administered in randomized order using a 32G needle. Pain was assessed using a Visual Analogue Scale (VAS) immediately after each injection. The primary outcome was the difference in mean VAS scores between techniques. Secondary analyses examined the effects of age and gender on pain perception. Results The mean VAS score for intradermal injections was significantly higher than for subdermal injections (6.18 vs. 3.85, p<0.001). No significant gender-based differences were observed. Patients under 40 reported higher intradermal pain than older subjects (p=0.04), but age had no impact on subdermal pain. Conclusion Subdermal PDLLA injections are significantly less painful than intradermal injections, likely due to lower nerve density and reduced dermal resistance. With equivalent efficacy and minimal downtime, subdermal injection may be preferable for patient comfort and compliance. Level of Evidence V This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authorswww.springer.com/00266
- 7 January 2026
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 50 (11) , 4212-4217
Comparative Pain Assessment of Intradermal Versus Subdermal Skin Booster Injections Using PDLLA: A Randomized, Double-Blinded Split-Injection Study
Background Poly-D,L-lactic acid (PDLLA) skin boosters are widely used for biostimulatory skin rejuvenation, but comparative data on pain perception between injection techniques remain limited. Objective To compare patient-reported pain between intradermal and subdermal PDLLA injections using a randomized, double-blinded, split-injection design. Methods Twenty-one healthy participants (aged 27–64) each received ten facial injections: five intradermal and five subdermal, administered in randomized order using a 32G needle. Pain was assessed using a Visual Analogue Scale (VAS) immediately after each injection. The primary outcome was the difference in mean VAS scores between techniques. Secondary analyses examined the effects of age and gender on pain perception. Results The mean VAS score for intradermal injections was significantly higher than for subdermal injections (6.18 vs. 3.85, p<0.001). No significant gender-based differences were observed. Patients under 40 reported higher intradermal pain than older subjects (p=0.04), but age had no impact on subdermal pain. Conclusion Subdermal PDLLA injections are significantly less painful than intradermal injections, likely due to lower nerve density and reduced dermal resistance. With equivalent efficacy and minimal downtime, subdermal injection may be preferable for patient comfort and compliance. Level of Evidence V This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authorswww.springer.com/00266
- Open Access
- 20 December 2025
- Published by Elsevier in JPRAS Open
- Vol. 48, 1069-1072
Compensatory hypertrophy of the superior gluteus maximus following botulinum toxin-induced weakening of the inferior fibers
- 20 December 2025
- Published by Elsevier in JPRAS Open
- Vol. 48, 1069-1072
Open AccessCompensatory hypertrophy of the superior gluteus maximus following botulinum toxin-induced weakening of the inferior fibers
- Open Access
- 12 December 2025
- Published by Elsevier in JPRAS Open
- Vol. 48, 691-696
Clavicular augmentation with hyaluronic acid six-point technique: A novel non-surgical approach to skeletal definition
- 12 December 2025
- Published by Elsevier in JPRAS Open
- Vol. 48, 691-696
Open AccessClavicular augmentation with hyaluronic acid six-point technique: A novel non-surgical approach to skeletal definition
- Open Access
- 24 November 2025
- Published by MDPI AG in Scientia Pharmaceutica
- Vol. 93 (4) , 62
Injectable Biostimulator in Adipose Tissue: An Update and Literature Review
Injectable biostimulatory agents such as poly-L-lactic acid (PLLA), polycaprolactone (PCL), and calcium hydroxyapatite (CaHA) have emerged as key tools in regenerative aesthetics due to their ability to stimulate adipogenesis and adipocyte metabolic activity, enhance collagen production, and improve dermal quality. This review aimed to provide an updated synthesis of the role of these agents in adipocyte stimulation, focusing on their mechanisms of action, clinical efficacy, and therapeutic applications. A comprehensive search of the MEDLINE, PubMed, and Ovid databases was conducted for studies published from 2018 onward, including in vitro and in vivo experiments, randomized controlled trials, and observational studies, which were evaluated according to the Oxford Centre for Evidence-Based Medicine hierarchy. The findings demonstrated that PCL promotes adipose-derived stem cell differentiation and extracellular matrix remodeling, while PLLA exhibits dual effects on collagen synthesis and adipocyte stimulation, with clinical trials such as the SPLASH study confirming significant improvements in dermal thickness and adipogenesis. CaHA provided immediate volumizing benefits with long-term tissue regeneration, and innovative approaches including combination therapies and novel injection protocols expanded clinical applications. Overall, PLLA, PCL, and CaHA represent effective and versatile biostimulatory agents that support natural and durable outcomes in aesthetic practice. Nevertheless, the absence of large-scale trials and standardized protocols highlights the need for further research to optimize safety, efficacy, and long-term treatment strategies.
- 24 November 2025
- Published by MDPI AG in Scientia Pharmaceutica
- Vol. 93 (4) , 62
Open AccessInjectable Biostimulator in Adipose Tissue: An Update and Literature Review
Injectable biostimulatory agents such as poly-L-lactic acid (PLLA), polycaprolactone (PCL), and calcium hydroxyapatite (CaHA) have emerged as key tools in regenerative aesthetics due to their ability to stimulate adipogenesis and adipocyte metabolic activity, enhance collagen production, and improve dermal quality. This review aimed to provide an updated synthesis of the role of these agents in adipocyte stimulation, focusing on their mechanisms of action, clinical efficacy, and therapeutic applications. A comprehensive search of the MEDLINE, PubMed, and Ovid databases was conducted for studies published from 2018 onward, including in vitro and in vivo experiments, randomized controlled trials, and observational studies, which were evaluated according to the Oxford Centre for Evidence-Based Medicine hierarchy. The findings demonstrated that PCL promotes adipose-derived stem cell differentiation and extracellular matrix remodeling, while PLLA exhibits dual effects on collagen synthesis and adipocyte stimulation, with clinical trials such as the SPLASH study confirming significant improvements in dermal thickness and adipogenesis. CaHA provided immediate volumizing benefits with long-term tissue regeneration, and innovative approaches including combination therapies and novel injection protocols expanded clinical applications. Overall, PLLA, PCL, and CaHA represent effective and versatile biostimulatory agents that support natural and durable outcomes in aesthetic practice. Nevertheless, the absence of large-scale trials and standardized protocols highlights the need for further research to optimize safety, efficacy, and long-term treatment strategies.
- Open Access
- 20 November 2025
- Published by Elsevier in JPRAS Open
- Vol. 48, 567-584
Exosomes in trichology: A literature review
- 20 November 2025
- Published by Elsevier in JPRAS Open
- Vol. 48, 567-584
Open AccessExosomes in trichology: A literature review